
INTRAPRO-60
MRP: 1,050
Packaging: 60MG
Pack Type: injection
Composition:
Cerebroprotein Hydrolysate 60mg
Indication:
For amelioration of cranial injury, cerebrovascular pathological sequelae and aprosexia in dementia.
Description:
Cerebroprotein Hydrolysate 60mg is a neuroprotective peptide-based injection derived from porcine brain proteins. It is widely used in the treatment of neurological disorders such as stroke, traumatic brain injury (TBI), Alzheimer’s disease, dementia, cognitive impairment, and Parkinsonism. It works by improving neuronal metabolism, synaptic transmission, and promoting nerve repair and neuroregeneration. The injection is administered intramuscularly or intravenously under professional supervision.
Tags:
- Supports brain tissue regeneration and repair
- Enhances cognitive function and memory
- Aids in recovery after stroke or traumatic brain injury
- Improves synaptic activity and neuronal metabolism
- Slows neurodegenerative progression in Alzheimer's or Parkinson's
Usage Information
Dosage
Typical Adult Dose: 60mg once daily for 10–20 days Route: Intravenous (IV) or intramuscular (IM) injection Course Duration: May vary based on condition and clinical judgment Note: Should be administered only by a healthcare professional
Side Effects
Mild headache Dizziness or fatigue Nausea Injection site pain Rare: Allergic reactions (rash, itching) No serious adverse effects reported in most clinical settings Important: Monitor for any signs of allergic response, especially on first dose.
Contraindications
Hypersensitivity to cerebroprotein or excipients Pregnancy and lactation (unless benefits outweigh risks) Not recommended in patients with severe renal or hepatic impairment Should not be used in pediatric patients unless advised by a neurologist
Availability
Cerebroprotein Hydrolysate 60mg injection Neuroprotective injection for stroke Brain injury treatment injection Cerebroprotein Hydrolysate uses Cognitive impairment therapy Injection for dementia and Parkinson's Cerebroprotein Hydrolysate dosage Brain peptide neurotrophic therapy
